C3 Research Associates
Avance Clinical is a full-service Contract Research Organization (CRO) headquartered in Australia with operations across New Zealand, Asia, North America, and Europe. It specializes in early-phase clinical trials for biotechs, leveraging advantages such as rapid ethics approval, no IND requirement, and a 43.5% R&D tax rebate in Australia to accelerate clinical success. The company offers comprehensive services from preclinical development through late-phase studies, focusing on agility, innovation, and cost-effectiveness. Avance Clinical has expertise in over 250 indications across all therapeutic areas and delivers data accepted by global regulators including the FDA, EMA, and TGA. Its personalized service model and proprietary GlobalReady process provide a seamless global drug development roadmap, integrating early and late-phase clinical operations with advanced technology including AI and real-world data. The company is recognized for its operational excellence and strategic innovation, serving biotechs with a global footprint and a strong reputation in the biotech CRO market.
C3 Research Associates
Avance Clinical is a full-service Contract Research Organization (CRO) headquartered in Australia with operations across New Zealand, Asia, North America, and Europe. It specializes in early-phase clinical trials for biotechs, leveraging advantages such as rapid ethics approval, no IND requirement, and a 43.5% R&D tax rebate in Australia to accelerate clinical success. The company offers comprehensive services from preclinical development through late-phase studies, focusing on agility, innovation, and cost-effectiveness. Avance Clinical has expertise in over 250 indications across all therapeutic areas and delivers data accepted by global regulators including the FDA, EMA, and TGA. Its personalized service model and proprietary GlobalReady process provide a seamless global drug development roadmap, integrating early and late-phase clinical operations with advanced technology including AI and real-world data. The company is recognized for its operational excellence and strategic innovation, serving biotechs with a global footprint and a strong reputation in the biotech CRO market.